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ABSTRACT: Bio-orthogonal reactions have become an essential
tool to prepare biomaterials; for example, in the synthesis of
nanocarriers, bio-orthogonal chemistry allows circumventing
common obstacles related to the encapsulation of delicate payloads
or the occurrence of uncontrolled side reactions, which
significantly limit the range of potential payloads to encapsulate.
Here, we report a new approach to prepare pH-responsive
nanocarriers using dynamic bio-orthogonal chemistry. The
reaction between a poly(hydrazide) crosslinker and functionalized
polysaccharides was used to form a pH-responsive hydrazone
network. The network formation occurred at the interface of aqueous nanodroplets in miniemulsion and led to the production of
nanocapsules that were able to encapsulate payloads of different molecular weights. The resulting nanocapsules displayed low
cytotoxicity and were able to release the encapsulated payload, in a controlled manner, under mildly acidic conditions.
■ INTRODUCTION
The lack of selectivity during the preparation of biomaterials is
a significant obstacle in the development of new functional
materials for biomedical applications such as nanocarriers
(NCs). Bio-orthogonal chemistries, reactions occurring
uniquely, or at least preferentially, between functional groups
of synthetic origin that can proceed under physiological
conditions without interfering with the activity of other
functional groups of the biomolecules, are an attractive
solution to this lack of selectivity.1 Those reactions have
become an essential tool for the labeling, conjugation, and
surface modification of biomolecules because of their chemical
selectivity and biocompatibility.2−4 Implementing such chem-
istries in the design of new polymer NCs can potentially allow
for the encapsulation of delicate payloads.5−7
Polymer NCs prepared by polycondensation at the interface
of a water-in-oil miniemulsion are promising candidates for
gene and drug delivery.8,9 The advantages of these NCs in
comparison to other nanovehicles are their relatively low
polymer content for the formation of a capsule shell and high
loading capacity.10−12 The interfacial crosslinking reaction of
inverse-miniemulsion droplets is an ideal technique to
encapsulate a variety of hydrophilic payloads.12−14 However,
in the past, their preparation usually relied on nonselective
reactions, which are detrimental to the final behavior of the
NCs such as the efficacy of the release of the payload or to the
biodegradability of the carriers. For example, the reaction
between multifunctional alcohols, amines, or thiols and
diisocyanate compounds has shown the efficient encapsulation
of a variety of payloads in polyurea, polyurethane, or
polythiourea nanocapsules.15,16 However, such reactions
involving nucleophiles like alcohols and amines that are also
present in sensitive biomolecules used as payloads could lead
to side reactions and cause a partial or total decrease in the
efficacy of the payload.
A method to avoid unwanted side-reactions consists in
integrating bio-orthogonal chemistry to the interfacial synthesis
of NCs, and this approach would be beneficial to the
development of new and more efficient NCs for drug release
or gene therapy.17 Bio-orthogonal reactions such as olefin
metathesis and copper-catalyzed azide-alkyne click reaction
have been successfully used to prepare nanocarriers.18−20
Although these chemistries displayed the desired selectivity,
they still required the use of catalysts; this led to the
implementation of catalyst-free reactions in the development
of nanocapsules; for example, the copper-free click-reaction
between a tetrazole functionalized protein and crosslinker
functionalized with cyclic alkenes was successfully used to
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prepare NCs.7 These reactions are attractive strategies for the
successful encapsulation of biomolecules and therapeutic
substances. However, milder alternatives and more compliant
bio-orthogonal chemistries still need to be implemented in the
production of NCs to offer the broad range of reaction
conditions needed to satisfy the requirements for the
encapsulation of different complexes and sensitive payloads.
One of such chemistries would be to use the reaction between
hydrazide and ketone to form a crosslinked NC shell. This
reaction occurs in aqueous media, at a physiological pH value
and room temperature without the addition of any chemical,
leads to the formation of a hydrazone ligation, and has been
used for the labeling of protein,21 DNA, RNA,22 and cells.23
Furthermore, interestingly for the design of drug delivery
devices, the hydrazone bond has a limited hydrolytic stability
and can dissociate under acidic conditions.24−26
Here, to prepare NCs compliant with the delivery of active
molecules within weak acidic environments such as tumor
sites, inflammatory tissues, or intracellular compartments like
endosomes and lysosomes, the interfacial reaction between a
poly(aldehyde) or poly(ketone), derived from polysaccharides,
dissolved in water nanodroplets and an oil-soluble poly-
(hydrazide) was used to create the shell of responsive NCs by
interfacial polycondensation (Figure 1). Furthermore, since the
pH value of the environment can influence the hydrazone
network created, it was used, as a result, for the controlled
release of the payload.27 The bio-orthogonal reaction between
reactive carbonyl and acyl hydrazine led to the synthesis of pH-
responsive NCs based on functionalized dextran. Additionally,
the release from the resulting NCs was controlled, under
physiologically relevant conditions, by the degree of cross-
linking of the hydrazone network tuned by the pH-responsive
nature of equilibrium between hydrazide and hydrazone.
■ EXPERIMENTAL SECTION
Synthesis of the Nanocarriers. The precursors for the synthesis
of the NCs, aldehyde-functionalized dextran (OxD), ketone-function-
alized dextran (KeD), and poly(styrene-co-methacryloyl hydrazide)
(PSH), were prepared as described in the Supporting Information
(Figures S1−S3 and Table S1). The NC synthesis was carried out by
the interfacial reaction between functionalized dextran, either OxD or
KeD, in aqueous droplets, and PSH in the continuous toluene phase.
The water phase was prepared by dissolving 150 mg of functionalized
dextran and 16 mg of NaCl in 1 g of phosphate buffer solution (20
mM). For the NCs used for in vitro studies, a mixture of 5 wt % of
Cy5-labeled OxD (or KeD) and 95 wt % of unlabeled OxD (or KeD)
was used. As a model payload, 5 mg of rhodamine-labeled dextran of
different molecular weights (either 150 or 500 kDa) was added to the
aqueous phase. The continuous oil phase was prepared by adding 160
mg of PGPR to 10 g of toluene. The oil phase was added dropwise to
the stirred water phase to form an inverse pre-emulsion. Then, the
pre-emulsion was passed 2 times through a microfluidizer (LV1)
equipped with a Y-shape interaction chamber with 75 μm channels at
a pressure of 896.3 bar, resulting in the formation of a miniemulsion.
A second oil phase was prepared by dissolving 90 mg of PGPR and
150 mg of PSH in 4 g of toluene. After the dropwise addition of the
second oil phase to the stirred miniemulsion, the reaction mixture was
stirred for 24 h at room temperature. The NCs were purified by two
cycles of centrifugation (1770 RCF) followed by redispersion in pure
toluene. To transfer the NCs to water, 1 g of the toluene dispersion
was added dropwise, under gentle sonication, to 3 g of a 0.1 wt %
solution of sodium dodecylsulfate (SDS) in PBS buffer. After the
addition, the samples were stirred in open vials for 6 h at room
temperature to evaporate the toluene. Then, the excess SDS was
removed using centrifugal concentrators (pore size 1000 kDa)
followed by redispersion in fresh PBS buffer.
Release Kinetics. The release of the payload was measured by
fluorescence spectroscopy after the centrifugal ultrafiltration of the
nanocapsule suspensions incubated for different periods of time in
buffer solution at controlled pH values. After the transfer of the NCs
to water, 10 mL of the suspension was filtered by centrifugal
ultrafiltration at 1770 RCF using Vivaspin 1000 K centrifugal
concentrators. The NCs collected on the filter were redispersed in
4 mL of phosphate buffer pH = 7.4, yielding a suspension of NCs of
ca. 3 mg/mL. Then, after appropriate time intervals (0, 0.5, 1, and 3
h), 250 μL of the suspension was taken out and filtered by centrifugal
ultrafiltration at 1770 RCF for 15 min using a spin filter (vivaspin 500
μL 1000 K), and the fluorescence of the filtrate was measured at λex =
548 nm and λem = 576 nm.
After 3 h, the sample was split in three aliquots of 1 mL, and each
aliquot was diluted by the addition of 2 mL of a solution at the
appropriate pH value to yield final suspensions of a concentration of
ca. 1 mg/mL at a pH value of 7.4, 6, or 5.2. Then, at appropriate time
intervals (0, 1, 3, 6, 24, 48, 72, 96, 112, 136, and 168 h), 250 μL of the
suspension was taken out and centrifuged at 1770 RCF for 15 min
using a spin filter (vivaspin 500 μL 1000 K). The concentration of the
payload released was measured from the fluorescence intensity of the
filtrate.
Cell Viability and Cellular Nanocarrier Uptake. The viability
of the cells was quantified with the CellTiter-Glo luminescent cell
viability assay (Promega, Germany) after coincubation of the cells
with the NC suspension with a concentration ranging from 37.5 to
300 μg/mL for 2, 24, and 48 h. The uptake of the NCs by the HeLa
cells was quantified by flow cytometry after the coincubation of the
cells with a suspension of 75 μg/mL for 2, 24, and 48 h. The uptake
was also visualized by confocal fluorescence microscopy after 48 h of
Figure 1. Synthesis of dextran-based pH-responsive and bio-orthogonal hydrazone nanocarriers.
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the coincubation of the cells with a suspension of NCs at a
concentration of 75 μg/mL. Details of the in vitro experiments are
described in the Supporting Information.
■ RESULTS AND DISCUSSION
The NCs were prepared by the crosslinking of functionalized
dextran, either aldehyde-functionalized dextran (OxD) or
ketone-functionalized dextran (KeD) (Figure 2) with poly-
(styrene-co-methacryloyl hydrazide) (PSH). The reaction of
the functionalized dextran with the PSH resulted in the
formation of a network of hydrazone linkages. To prepare the
NCs, the dextran derivatives were dissolved in water and the
PSH was dissolved in toluene. Then, the crosslinking reaction
between the dextran derivatives and the PSH occurred at the
interface of the stable aqueous nanodroplets in miniemulsion.
This resulted in the formation of nanocapsules of uniform size
and limited size distribution (Figure 3, Figure S4). Table 1
summarizes the properties of the resulting nanocapsules. The
size of the NCs was controlled by the size of the parent
precursor droplets (Figure S5), itself tunable by controlling the
emulsification conditions.16,28 The nanocapsules prepared with
the aldehyde-functionalized dextran (OxD) were labeled
OxDNC, the nanocapsules prepared with the ketone-function-
alized dextran (KeD) were labeled KeDNC, and nanocapsules
prepared with a mixture of OxD and KeD were labeled
OxDxKeDyNC, where “x” and “y” are the weight fractions of
OxD and KeD, respectively. Furthermore, nanocarriers were
prepared by the addition of different molar ratios of hydrazide
and reactive carbonyls; during the preparation of OxDNCz, “z”
molar equivalents of hydrazide groups were added to the
continuous phase in comparison to the water phase containing
1 molar equivalent of aldehydes.
Independent of the dextran derivative used, the size of the
NCs in toluene was ca. 200 nm (Table 1). The size of the NCs
was not significantly affected by the ratio of crosslinker
molecules in the feed; similarly, the dry thickness of the shell of
the NCs remained constant (Figure S6). After transfer to
water, the NCs systematically swelled. As the molar ratio of the
crosslinker to reactive groups on the dextran increased, a
moderate decrease in the swelling was observed (Table 1),
likely caused by the increase in the hydrophobic nature of the
crosslinked network induced by the incorporation of more
polystyrene-based crosslinkers and the increase in the cross-
linking density of the shell. After transfer to water, the NCs
also displayed a negative zeta potential attributed to remaining
traces of the surfactant (SDS) used during the transfer of the
NCs to water. Furthermore, those NCs showed excellent
stability in aqueous media, and no significant changes in size
and size distribution were observed even 6 months after their
transfer to PBS buffer (Figure S7).
The preparation of the NCs was adjusted to yield the
highest apparent encapsulation efficiency of model payloads.
The apparent encapsulation efficiency was measured by the
fraction of the payload used in the preparation of the dispersed
Figure 2. Dextran functionalized either with aldehyde groups (OxD)
(red) or with ketone groups (KeD) (blue).
Figure 3. (A, B) TEM and (C, D) SEM images of the KeDNC0.5 and
OxDNC0.5 nanocarriers. The scale bars are 200 nm.
Table 1. Characteristics of the Crosslinked Dextran Nanocarriers Synthesized
nanocarrier dextran hydrazide /reactive carbonyl ratio
average size (nm) PDI
zeta potential (mV)toluene water toluene water
OxDNC0.25 OxD 100 wt % 0.25 190 270 0.16 0.29 −8.8
OxDNC0.5 0.5 230 294 0.19 0.20 −7.25
OxDNC1 1 200 260 0.15 0.13 −3.66
OxDNC1.5 1.5 211 250 0.17 0.20 −1.55
KeDNC0.25 KeD 100 wt % 0.25 200 320 0.21 0.20 −18.4
KeDNC0.5 0.5 208 250 0.20 0.15 −15.2
KeDNC1 1 210 290 0.20 0.17 −11.3
KeDNC1.5 1.5 226 260 0.22 0.23 −1.14
OxD50KeD50NC0.5 OxD 50 wt % + KeD 50 wt % 0.5 190 250 0.19 0.25 −21.4
OxD25KeD75NC0.5 OxD 25 wt % + KeD 75 wt % 0.5 201 280 0.21 0.26 −20.0
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phase present in the NCs after their transfer and equilibration
in PBS buffer and accounts for both the payload molecules that
were not encapsulated and those released in the first 6 h
following the transfer to water (corresponding to the time
needed to complete the water transfer process). First, a series
of dextrans of different molecular weights functionalized with
rhodamine were used to determine the molecular weight cut-
off for the successful encapsulation in the OxDNC0.5 and
KeDNC0.5 (Figure 4A). Only macromolecular payloads could
efficiently be loaded in the nanocapsules, in addition to the
model dextran with different molecular weights; other
molecules such as albumin (Mn: 67 kDa) were also
encapsulated in both OxDNC and KeDNC (Figure S8). The
apparent encapsulation of payloads was systematically more
efficient in the aldehyde-functionalized OxDNC0.5s than in the
ketone-functionalized KeDNC0.5s, likely because the equili-
brium constant for the reaction of an acyl hydrazide with an
aldehyde is typically larger than that for the reaction with a
ketone;29 thus, the reaction of the polyaldehyde precursor with
the polyhydrazide crosslinker formed a denser and more
heavily crosslinked network in comparison to the reaction of
the polyketone in the same conditions.30 This led to the more
efficient encapsulation of smaller payloads in the OxDNCs
than in the KeDNCs.
Because of the existence of this dynamic equilibrium
between reacted and unreacted hydrazine and reactive
carbonyl moieties, the stoichiometry of the reactant present
during the reaction also affects the formation of a dense
crosslinked network.24 The results show (Figure 4B) that
having an equimolar amount of ketone and hydrazide led to
the highest encapsulation efficiency of the payloads.
Furthermore, the ionic strength of the environment also
influenced the encapsulation efficiency (Figure 4C); an
increase in the concentration of the phosphate buffer used
during the preparation of the OxDNC0.5 and KeDNC0.5
resulted in an improved encapsulation efficiency of the
payloads, likely because of the accelerated reaction kinetic of
hydrazone formation in the presence of ions.31,32
The acylhydrazone crosslinking points formed by the
reaction of the functionalized dextran and the PSH are
dynamic covalent bonds, which can undergo a reversible
disassembly when the environment is changed.33 The assembly
and disassembly of the acylhydrazone bonds in the network
can be controlled by changing the pH value of the
environment and can be used to trigger the release of the
cargo. The release of the payload from the NCs was the result
of the diffusion of the payload through the semi-permeable
shell of the NCs. The permeability of the membrane was
mostly affected by the crosslinking density, which can be tuned
by the amount of crosslinking agent used but also by the pH
value of the environment because of the dynamic nature of the
hydrazine network. To study the stability of the NCs at
different pH values and to study the effect of the acidity on the
stability of the acylhydrazone network, NCs were prepared
with either aldehyde-functionalized dextran (OxDNC0.5) or
with ketone-functionalized dextran (KeDNC0.5), and the
resulting NCs were transferred to PBS buffer pH = 7.4 at a
concentration of ca. 3 mg/mL. The release from those NCs
was studied over 3 h, and for all NCs, no or very limited release
of the encapsulated payload was measured. Then, the
suspension of NCs was diluted by the addition of 2-fold of
acidic buffer, and the final pH value of the suspension was
Figure 4. Encapsulation efficiency of the payloads in the nanocarriers
prepared under different conditions. (A) Influence of the size of the
model payloads, a series of dextran of different molecular weights
functionalized with rhodamine, on their encapsulation in OxDNC0.5
(black) and KeDNC0.5 (red). (B) Influence of the stoichiometry of
hydrazide and reactive carbonyl used during the synthesis of the
nanocarriers for OxDNCx (black) and KeDNCx (red) on the
encapsulation of rhodamine-functionalized dextran (Mn: 500 kDa).
(C) Influence of the concentration of the phosphate buffer used in the
precursor nanodroplets for OxDNC0.5 (black) and KeDNC0.5 (red)
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either 5.2, 6, or 7.4 at a concentration of ca. 1 mg/mL of NCs
in the suspension.
The type of reactive carbonyl group used, ketone or
aldehyde, influenced the release kinetic as much as the pH
value of the environment. NCs prepared with the OxD
displayed a minimal release of the cargos at every pH value
studied (Figure 5B). Inversely, the NCs prepared with KeD,
displayed a release of 5 to 10% of the cargo after 24 h in
suspensions at a pH value of 7.4, and between 45 and 60% of
the cargo released when in suspensions at a pH value of 5.2.
The increased release of the payload observed under acidic
conditions was ascribed to the disassembly of the acylhy-
drazone crosslinking points and an effective decrease in the
crosslinking density of the network in acidic media leading to
an increased permeability of the shell of the NCs.
The cumulative release of the cargo from KeDNC0.5 was
slow at neutral pH but increased significantly as the pH value
of the suspension decreased (Figure 5A). At a pH value of 5.2,
the cumulative release increased faster than that at a pH value
of 6. This phenomenon occurred due to an increased
dissociation of the acid-sensitive acylhydrazone bonds when
the pH value decreased. The release from OxDNC0.5 (Figure
Figure 5. Effect of the pH value of the environment on the release of payloads from NCs prepared with (A) ketone-functionalized dextran
(KeDNC0.5) and (B) aldehyde-functionalized dextran (OxDNC0.5). Using rhodamine-functionalized dextran as the payload with a molecular
weight (1) Mn = 150 kDa and (2) Mn = 500 kDa. Measured at a pH value of 7.4 (■), 6.0 (●), and 5.2 (▲).
Figure 6. Effect of the composition of the dextran nanocarriers on the
release of the encapsulated payload (Mn = 500 kDa). For
OxD50KeD50NC0.5 (◆), OxD25KeD75NC0.5 (★), KeDN0.5 (⬟), and
OxDN0.5 (▼) at pH values of 7.4 (open symbols, dashed lines) and
5.2 (filled symbols, solid lines).
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5B) was only slightly responsive to changes in the acidity of the
suspension. These results can be attributed to the higher
thermodynamic stability of the acylhydrazone bonds formed
between aldehyde and hydrazide in comparison to those
formed between ketone and hydrazide.30,34 Figure 5 also
highlights the effect of size on the release of the payload from
the NCs. When the NCs were in an equilibrated state, for the
first 3 h of the release experiment, both the rhodamine-
functionalized dextran with a molecular of 150 kDa and the
rhodamine-functionalized dextran with a molecular of 500 kDa
were efficiently entrapped inside the NCs. Once the system
was diluted and acidified, both diffusion probes were released.
Still, the release rate of the smaller probe was significantly
higher (Figure S9) because the crosslinked network obstructed
more efficiently the mass transport of the largest probes.35
While the presence of the hydrazone network enables the
release triggered by an increase in the acidity of the NC
environment, the release also occurred in the presence of
dextranase, an enzyme able to degrade the functionalized-
dextran backbone and destroy the NCs (Figure S8).
The cumulative release of payloads from the NCs prepared
using a mixture of OxD and KeD with different mass ratios of
the two polymers was also studied. Similar to the encapsulation
in OxDNCs, in the mixed system of OxDKeDNC, an increase
in the apparent encapsulation efficiency of smaller payloads
was observed in comparison to the encapsulation in KeDNC0.5
due to the presence of the polyaldehyde precursor. The results
of the release from those OxDKeDNCs showed (Figure 6) that
increasing the ratio of OxD in the mixture of functionalized
dextran led to the synthesis of more stable NCs at a neutral pH
value. However, those NCs were also less pH-responsive than
those prepared with more KeD. The NC OxD25KeD75NC0.5
displayed the best combination of long-term stability at a pH
value of 7.4 and response to variations of the pH value of the
environment.
The cytotoxicity of ODNC0.5 and KDNC0.5 was evaluated in
HeLa cells using a luminescent cell viability assay (Figure 7A).
Both the OxDNC0.5 and KeDNC0.5 did not display any
cytotoxicity after 2 days of incubation even at concentrations
as high as 300 μg/mL. The cellular uptake of the NCs by HeLa
cells was measured using NCs functionalized with cyanine-5
(Cy5), a fluorescent tag. Those NCs also encapsulated another
fluorescent molecule, rhodamine-functionalized dextran (Mn =
500 kDa). The resulting fluorescent NCs were incubated for 2,
24, or 48 h with HeLa cells, and after washing off the free NCs,
the fluorescence of the cells was quantified by flow cytometry.
Figure 7. (A) Cell viabilities of HeLa cells after incubation with KeDNC0.5 and OxDNC0.5 measured after the incubation in cell media containing
37.5 to 300 μg/mL of nanocarriers. (B) Cellular uptake of KeDNC0.5 and OxDNC0.5 in HeLa cells after incubation for 2, 24, and 48 h in media
containing 75 μg/mL of nanocarriers. (C) Confocal fluorescence images of HeLa cells after 48 h of incubation with media containing 75 μg/mL of
nanocarriers. The scale bars are 20 μm.
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Flow cytometry showed that both OxDNC0.5 and KeDNC0.5
were taken up by the cells (Figure 7B). The fluorescence
intensity inside the cells increased with the coincubation time
in keeping with the continuous uptake of the NCs during
incubation. After 24 h of coincubation, ca. 60% of the HeLa
cells had internalized OxDNC0.5 and ca. 45% of the cells
contained KeDNC0.5 (Figure S10). Similar results were also
observed with the mixed dextran NCs (Figure S11). Finally,
confocal fluorescence microscopy was used to analyze the
localization of the NCs in the cells to understand the fate of
the OxDNC0.5 and KeDNC0.5 during their coincubation with
the cells. The colocalization studies in the HeLa cells were
performed with CellMask to identify the cellular membrane
and LysoTracker to identify the lysosomes (Figure 6C). For
most NCs taken up by the cells, both the rhodamine (from the
cargo) and the CY-5 (from the NC shell) were present at the
same location. Although the fluorescence signal from the NC
shells coming from the NCs contained within the more acidic
lysosomes seemed to overpower the signal from the cargo, to
ascertain the release of the encapsulated payload from the NCs
once in the lysosome, complementary release studies with
payloads having a specific effect on the cellular function would
be required.
■ CONCLUSIONS
In summary, we developed a robust and selective synthetic
method for the preparation of pH-responsive NCs. The bio-
orthogonal reaction between reactive carbonyl and hydrazide
groups was used to generate the crosslinked hydrazone shell of
the NCs, and the reaction occurred under biologically relevant
conditions. The resulting NCs were successfully taken up by
human HeLa cells without displaying any toxicity toward the
cells. Additionally, encapsulated payloads were released by a
variation in the pH value of the surrounding environment. The
release was ascribed to the variation of the effective
crosslinking density of the hydrazone network due to the
dynamic equilibrium of the reaction between the reactive
carbonyl and the hydrazide. The hydrazone crosslinking points
dissociated in mildly acidic environments and this pH-
triggered change allowed for the controlled release of the
payloads. The synthetic bio-orthogonal strategy used here can
be expanded to other precursors and is an appealing tool to
design controllable-release drug-delivery vehicles for the
encapsulation of sensitive drugs. Because the new nanocarriers
synthesized here were built using a bio-orthogonal reaction
and were able to encapsulate macromolecular payloads
successfully, they are ideal candidates for the delivery of
sensitive biomacromolecular therapeutic agents such as
protein, DNA, or RNA, and they could find applications in
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